Braveheart Bio market cap: $2.126 B

Biotechnology: Pharmaceutical Preparations, ranked by market cap

#104Zenas BioPharmaZBIO$2.15B
#105Nuvation BioNUVB$2.14B
#106Braveheart BioBRVE$2.13B
#107UroGen PharmaURGN$2.09B
#108Agios PharmaceuticalsAGIO$2.09B

Insiders buying

6 open-market purchases by officers and directors of Braveheart Bio, worth $157.4M. Grants and option exercises are excluded.

ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC$34.9M
1,940,000 shares at $18.00 on 7 Aug 2026 · filed 11 Aug 2026
Erez Chimovits$34.9M
1,940,000 shares at $18.00 on 7 Aug 2026 · filed 11 Aug 2026
AH Bio Fund IV, L.P., AH Equity Partners Bio IV, L.L.C., Marc L. Andreessen, Benjamin A. Horowitz$19.8M
1,100,000 shares at $18.00 on 7 Aug 2026 · filed 11 Aug 2026
Forbion Growth III Management B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., Forbion Ventures Fund VII Cooperatief U.A., Forbion Ventures VII Management B.V.$64.8M
3,600,000 shares at $18.00 on 7 Aug 2026 · filed 7 Aug 2026
Travis MurdochCEO and President$1.50M
83,333 shares at $18.00 on 7 Aug 2026 · filed 7 Aug 2026
Christopher Viehbacher$1.50M
83,333 shares at $18.00 on 7 Aug 2026 · filed 7 Aug 2026

What if Braveheart Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$335,787.60

Per share 14,222× higher

Bitcoin $1.74T

$19,343.35

Per share 819× higher

Nvidia $5.52T

$61,259.78

Per share 2,595× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Braveheart Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.